GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 208 filers reported holding GENMAB A/S in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,343,037 | -6.2% | 94,784 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $3,563,861 | +27.3% | 93,761 | +26.5% | 0.00% | 0.0% |
| Q1 2023 | $2,799,683 | +109262.6% | 74,144 | +22.7% | 0.00% | 0.0% |
| Q4 2022 | $2,560 | -99.9% | 60,415 | +10.1% | 0.00% | 0.0% |
| Q3 2022 | $1,763,000 | +2.2% | 54,862 | +3.3% | 0.00% | 0.0% |
| Q2 2022 | $1,725,000 | +161.4% | 53,098 | +191.1% | 0.00% | – |
| Q1 2022 | $660,000 | +8.0% | 18,243 | +18.1% | 0.00% | – |
| Q4 2021 | $611,000 | +135.0% | 15,451 | +160.0% | 0.00% | – |
| Q3 2021 | $260,000 | +20.4% | 5,942 | +12.5% | 0.00% | – |
| Q2 2021 | $216,000 | +0.5% | 5,282 | 0.0% | 0.00% | – |
| Q4 2020 | $215,000 | – | 5,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |